Registry of transcatheter aortic-valve implantation in high-risk patients

New England Journal of Medicine

Volumn 366, Issue 18, 2012, Pages 1705-1715

  Gilard, Martine ^a   Eltchaninoff, Hélène ^b   Iung, Bernard ^c   Donzeau Gouge, Patrick ^f   Chevreul, Karine ^d   Fajadet, Jean ^g   Leprince, Pascal ^e   Leguerrier, Alain ⁱ   Lievre, Michel ^j   Prat, Alain ^m   Teiger, Emmanuel ^d   Lefevre, Thierry ^f   Himbert, Dominique ^c   Tchetche, Didier ^g   Carrié, Didier ^h   Albat, Bernard ⁿ   Cribier, Alain ^b   Rioufol, Gilles ^p   Sudre, Arnaud ^m   Blanchard, Didier ^o   Collet, Frederic ^q,s   Dos Santos, Pierre ^w   Meneveau, Nicolas ^u   Tirouvanziam, Ashok ^x   Caussin, Christophe ^t   Guyon, Philippe ^v   Boschat, Jacques ^a   Le Breton, Herve ⁱ   Collart, Frederic ^q,s   Houel, Remi ^r   Delpine, Stephane ^y   Souteyrand, Geraud ^z   Favereau, Xavier ^aa   Ohlmann, Patrick ^ab   Doisy, Vincent ^k   Grollier, Gilles ^ac   Gommeaux, Antoine ^ad   Claudel, Jean Philippe ^l   Bourlon, Francois ^ag   Bertrand, Bernard ^ae   Van Belle, Eric ^m   Laskar, Marc ^af   more..

^a BREST UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c BICHAT HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f Institut Jacques Cartier   (France)

^g CLINIQUE PASTEUR   (France)

^h TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁱ RENNES UNIVERSITY HOSPITAL   (France)

^j UNIVERSITÉ LYON 1   (France)

^k Clinique Tonkin   (France)

^l Infirmerie Protestante   (France)

^m LILLE UNIVERSITY HOSPITAL   (France)

ⁿ MONTPELLIER UNIVERSITY HOSPITAL   (France)

^o Clinique Saint Gatien   (France)

^p HOSPICES CIVILS DE LYON   (France)

^q Hôpital Privé Clairval   (France)

^r HÔPITAL SAINT JOSEPH   (France)

^s TIMONE HOSPITAL   (France)

^t CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^u UNIVERSITY HOSPITAL OF BESANÇON   (France)

^v CENTRE CARDIOLOGIQUE DU NORD   (France)

^w BORDEAUX UNIVERSITY HOSPITAL   (France)

^x NANTES UNIVERSITY HOSPITAL   (France)

^y ANGERS UNIVERSITY HOSPITAL   (France)

^z UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^aa CMC Parly 2   (France)

^ab UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^ac CAEN UNIVERSITY HOSPITAL   (France)

^ad Polyclinique Bois Bernard   (France)

^ae GRENOBLE UNIVERSITY HOSPITAL   (France)

^af DUPUYTREN UNIVERSITY HOSPITAL   (France)

^ag Service de Physiologie   (Monaco)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FRANCE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; QUALITY CONTROL; RISK ASSESSMENT; STROKE; SURGICAL RISK; SYNDROME DELINEATION; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

EID: 84860436228     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1114705     Document Type: Article

References (28)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Disease. Eur Heart J 2003;24:1231-43. (Pubitemid 36834640)
2. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231. [Errata, Circulation 2007;115(15):e409, 2010; 121(23)e443.]
3. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68. (Pubitemid 46276943)
4. Melby SJ, Zierer A, Kaiser YP, et al. Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann Thorac Surg 2007;83:1651-7. (Pubitemid 46616744)
5. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009;88:Suppl:S23-S42.
6. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137:82-90.
7. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20. (Pubitemid 41746694)
8. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8. (Pubitemid 35440280)
9. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) Registry. Eur Heart J 2011;32:191-7.
10. Rodés-Cabau J, Dumont E, De LaRochellière R, et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008;102:1240-6.
11. Kahlert P, Erbel R. Transcatheter aortic valve implantation in the era after commercialization: quo vadis in the real world? Circulation 2011;123:239-41.
12. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
13. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122: 62-9.
14. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011;32:198-204.
15. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve Revalving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
16. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8.
17. Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011;12: 762-7.
18. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363: 1597-607.
19. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
20. Eltchaninoff H, Zajarias A, Tron C, et al. Transcatheter aortic valve implantation: technical aspects, results and indications. Arch Cardiovasc Dis 2008;101:126-32. (Pubitemid 351462744)
21. Walther T, Dewey T, Borger M, et al. Transapical aortic valve implantation: step by step. Ann Thorac Surg 2009;87:276-83.
22. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009;119:3009-16.
23. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current thirdgeneration self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
24. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011;32:205-17.
25. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33.
26. Kempfert J, Rastan A, Holzhey D, et al. Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circulation 2011; 124:Suppl:S124-S129.
27. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
28. Gotzmann M, Pljakic A, Bojara W, et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J 2011; 162(2):238.e1-245.e1.